No effect of the CYP1A2*1F genotype on thioridazine, mesoridazine, sulforidazine plasma concentrations in psychiatric patients

被引：4

作者：

Dorado, Pedro

Berecz, Roland

Penas-Lledo, Eva M.

de la Rubia, Alfredo

LLerena, Adrian

机构：

[1] Extremadura Univ Hosp, CICAB, Clin Res Ctr, Fac Med,Serv Extremeno Salud, E-06071 Badajoz, Spain

[2] Univ Debrecen, Med & Hlth Sci Ctr, Dept Psychiat, Debrecen, Hungary

[3] Merida Psychiat Hosp, Merida, Venezuela

[4] Univ Beira Interior, CICS, Covilha, Portugal

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2007年 / 63卷 / 05期

关键词：

D O I：

10.1007/s00228-007-0284-6

中图分类号：

R9 [药学];

学科分类号：

1007 [药学];

摘要：

引用

页码：527 / 528

页数：2

共 9 条

[1]

Thioridazine steady-state plasma concentrations are influenced by tobacco smoking and CYP2D6, but not by the CYP2C9 genotype [J].

Berecz, R ;

de la Rubia, A ;

Dorado, P ;

Fernández-Salguero, P ;

Dahl, ML ;

Llerena, A .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 59 (01) :45-50

[2]

THE INFLUENCE OF ENVIRONMENTAL AND GENETIC-FACTORS ON CYP2D6, CYP1A2 AND UDP-GLUCURONOSYLTRANSFERASES IN MAN USING SPARTEINE, CAFFEINE, AND PARACETAMOL AS PROBES [J].

BOCK, KW ;

SCHRENK, D ;

FORSTER, A ;

GRIESE, EU ;

MORIKE, K ;

BROCKMEIER, D ;

EICHELBAUM, M .

PHARMACOGENETICS, 1994, 4 (04) :209-218

[3]

Pharmacokinetic interaction of fluvoxamine and thioridazine in schizophrenic patients [J].

Carrillo, JA ;

Ramos, SI ;

Herraiz, AG ;

Llerena, A ;

Agundez, JAG ;

Berecz, R ;

Duran, M ;

Benítez, J .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (06) :494-499

[4]

Use of the mesoridazine/thioridazine ratio as a marker for CYP2D6 enzyme activity [J].

Llerena, A ;

Berecz, R ;

de la Rubia, A ;

Norberto, MJ ;

Benítez, J .

THERAPEUTIC DRUG MONITORING, 2000, 22 (04) :397-401

[5]

Schizophrenia and tobacco smoking in a Spanish psychiatric hospital [J].

LLerena, A ;

de la Rubia, A ;

Peñas-Lledó, EM ;

Diaz, FJ ;

de Leon, J .

SCHIZOPHRENIA RESEARCH, 2002, 58 (2-3) :323-327

[6]

Effect of thioridazine dosage on the debrisoquine hydroxylation phenotype in psychiatric patients with different CYP2D6 genotypes [J].

Llerena, A ;

Berecz, R ;

de la Rubia, A ;

Fernández-Salguero, P ;

Dorado, P .

THERAPEUTIC DRUG MONITORING, 2001, 23 (06) :616-620

[7]

MacLeod S. L., 1998, Proceedings of the American Association for Cancer Research Annual Meeting, V39, P396

[8]

Functional significance of a C→A polymorphism in intron I of the cytochrome P450 CYP1A2 gene tested with caffeine [J].

Sachse, C ;

Brochmöller, J ;

Bauer, S ;

Roots, I .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 47 (04) :445-449

[9]

Characterization of human cytochrome P450 enzymes involved in the metabolism of the piperidine-type phenothiazine neuroleptic thioridazine [J].

Wojcikowski, J ;

Maurel, P ;

Daniel, WA .

DRUG METABOLISM AND DISPOSITION, 2006, 34 (03) :471-476

← 1 →